The purpose of this study is to compare the effects of aerobic exercise training during and after chemotherapy for women who have recently been diagnosed with early-stage breast cancer. The participant will be instructed to self-report the session information to ExOnc staff at or before their next scheduled visit. If the participant's next scheduled visit is greater than 72 hours following an unsupervised session, ExOnc staff may reach out to the participant to retrieve the session information. Unsupervised session details will be source documented by ExOnc staff.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Enrollment
144
Subjects will be given material regarding cancer and it's impact.
Patients that elect supervised home based training platform or plan to complete unsupervised training sessions will receive a study kit which includes a heart rate monitor, blood pressure cuff, treadmill and tablet to complete aerobic training requirements. The study kit will be given to the patient upon completion of their baseline testing. The treadmill will be shipped to the patient's home and coordinated by the Ex Onc group. The treadmills are MSK owned equipment that will be deployed to the patient's homes via the vendor TechnoGym. A member of Ex Onc will provide an orientation session for the patient to set up all study kit items. If there is a delay in the patient receiving the treadmill , or any other unforeseen circumstance, patients may be assigned a temporary unsupervised training program until the treadmill is delivered.
Memorial Sloan Kettering Cancer Center
New York, New York, United States
Change in VO2 peak (functional capacity)
To determine the optimal timing of aerobic activity, relative to an attention-control group, on exercise capacity in a breast cancer setting. This will be evaluated using an electronic motorized treadmill test with 12-lead ECG monitoring (Mac® 5000, GE Healthcare) performed by certified exercise physiologists.
Time frame: during chemotherapy 3-6 months depending on treatment recommendations
Quality of Life measured by questionnaire during and after Chemotherapy
Determine the effects on patient-reported outcomes. Time frame can vary based on individual length of chemotherapy.
Time frame: at baseline, mid-point (12 weeks approximately) , and follow-up (24 weeks approximately) testing
Sleeping patterns as measured by questionnaire during and after Chemotherapy
Determine the effects on patient-reported outcomes. Time frame can vary based on individual length of chemotherapy.
Time frame: at baseline, mid-point (12 weeks approximately) , and follow-up (24 weeks approximately) testing
Depression scale during and after Chemotherapy
Determine the effects on patient-reported outcomes. Time frame can vary based on individual length of chemotherapy.
Time frame: at baseline, mid-point (12 weeks approximately) , and follow-up (24 weeks approximately) testing
Physical activity recall during and after Chemotherapy
Determine the effects on patient-reported outcomes. Time frame can vary based on individual length of chemotherapy.
Time frame: at baseline, mid-point (12 weeks approximately) , and follow-up (24 weeks approximately) testing
Skeletal Muscle Function
To examine the physiological mediators of the exercise training - exercise capacity relationship (e.g., skeletal muscle function as assessed by a muscle biopsy)performed.
Time frame: at baseline, mid-point (12 weeks approximately) , and follow-up (24 weeks approximately) testing
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.